NCT00145145View on ClinicalTrials.gov

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

January 12, 2005

Primary Completion Date

April 7, 2005

Study Completion Date

April 28, 2008

Conditions
Malignant Melanoma
Interventions
BIOLOGICAL

MAGE-3.A1 peptide and CpG 7909

Trial Locations (2)

B-1200

Cliniques Universitaires Saint-Luc (UCL), Brussels

Ludwig Institute for Cancer Research, Brussels

Sponsors
All Listed Sponsors
lead

Ludwig Institute for Cancer Research

OTHER